FrancophonIA/ELRC3.0 huggingface dataset:
English: In patients with HIV infection, cases of pancreatitis and peripheral neuropathy (or paresthesia) have been reported.
Slovenian: Pri bolnikih, okuženih z virusom HIV, so poročali o primerih pankreatitisa in periferne nevropatije (ali parestezije).
English: Patients should be advised that therapy with lamivudine has not been proven to reduce the risk of transmission of hepatitis B virus to others and therefore, appropriate precautions should still be taken.
Slovenian: Bolnikom je treba razložiti, da ni dokazano, da bi zdravljenje z lamivudinom zmanjšalo tveganje za prenos virusa hepatitisa B na druge, tako da so še vedno potrebni ustrezni varnostni ukrepi.
English: Adverse reactions are listed below by system organ class and frequency.
Slovenian: Neželeni učinki so našteti spodaj glede na organski sistem in pogostnost.
English: When doses below 100 mg are required Zeffix oral solution should be used (see Table 1 below).
Slovenian: Če so potrebni odmerki manjši od 100 mg, je treba uporabiti zdravilo Zeffix peroralno raztopino (glejte preglednico 1 spodaj).
English: Not everyone responds to treatment with Zeffix in the same way.
Slovenian: Na zdravljenje z zdravilom Zeffix se ne odzove vsak človek enako.
English: As the in vitro mutagenic activity of lamivudine could not be confirmed by in vivo tests, it is concluded that lamivudine should not represent a genotoxic hazard to patients undergoing treatment.
Slovenian: Ker se in vitro mutagene aktivnosti lamivudina z in vivo testi ni dalo potrditi, se sklepa, da lamivudin med zdravljenjem bolnikov ne bi smel predstavljati genotoksičnega tveganja.
English: In assays relating to potential substance effects on mitochondrial structure and DNA content and function, lamivudine lacked appreciable toxic effects.
Slovenian: V testiranjih potencialnih vplivov učinkovine na mitohondrijsko strukturo, vsebnost in funkcijo DNA, lamivudin ni imel znatnih toksičnih učinkov.
English: Lamivudine was not genotoxic in vivo at doses that gave plasma concentrations around 60-70 times higher than the anticipated clinical plasma levels.
Slovenian: Lamivudin in vivo ni bil genotoksičen pri odmerkih, s katerimi so bile dosežene v plazmi približno 60do 70-krat večje koncentracije od pričakovanih kliničnih plazemskih koncentracij.
English: Hepatitis B is a virus which infects the liver, causes long term (chronic) infection, and can lead to liver damage.
Slovenian: Virus hepatitisa B je virus, ki okuži jetra, povzroči dolgotrajno (kronično) okužbo in lahko vodi v okvaro jeter.
English: Animal studies with lamivudine showed an increase in early embryonic deaths in rabbits but not in rats (see section 5.3).
Slovenian: Študije na živalih z lamivudinom so pokazale porast zgodnjih smrti zarodkov pri kuncih, toda ne pri podganah (glejte poglavje 5.3).
English: It is also only a weak inhibitor of mammalian DNA polymerases alpha and beta.
Slovenian: Prav tako je le šibek zaviralec DNA polimeraz alfa in beta pri sesalcih.
English: Some people taking Zeffix or other similar medicines are more at risk of serious side effects.
Slovenian: Nekateri ljudje, ki jemljejo zdravilo Zeffix ali druga podobna zdravila, so bolj ogroženi zaradi resnih neželenih učnikov.
English: Accidentally taking too much Zeffix is unlikely to cause any serious problems.
Slovenian: Če po nesreči vzamete prevelik odmerek zdravila Zeffix, je malo verjetno, da bi prišlo do kakršnihkoli resnih težav.
English: Zeffix can be used in people whose liver is damaged, but still functions normally (compensated liver disease) and in combination with other medicines in people whose liver is damaged and does not function normally (decompensated liver disease).
Slovenian: Zdravilo Zeffix se lahko uporablja pri osebah, ki imajo okvarjena jetra, vendar jim jetra še vedno normalno delujejo (kompenzirana bolezen jeter), in v kombinaciji z drugimi zdravili pri osebah, ki imajo okvarjena jetra in jim ta ne delujejo normalno (dekompenzirana bolezen jeter).
English: Serum ALT and HBV DNA levels should be monitored at 3 month intervals and in HBeAg positive patients HBeAg should be assessed every 6 months.
Slovenian: Serumske vrednosti ALT in HBV DNA vrednosti je potrebno preveriti vsake 3 mesece in pri HBeAg pozitivnih bolnikih pa je HBeAg potrebno preveriti vsakih 6 mesecev.
English: In a retrospective study to determine the factors associated with HBV DNA breakthrough, 159 Asian HBeAg-positive patients were treated with lamivudine and followed up for a median period of almost 30 months.
Slovenian: V retrospektivni študiji za ugotovitev dejavnikov, povezanih s ponovnim povečanjem HBV DNA, je bilo 159 azijskih HBeAg-pozitivnih bolnikov, ki so se zdravili z lamivudinom in so jih spremljali mediano skoraj 30 mesecev.
English: This population primarily consisted of children with minimal hepatitis B. A dose of 3 mg/kg once daily (up to a maximum of 100 mg daily) was used in children aged 2 to 11 years and a dose of 100 mg once daily in adolescents aged 12 years and above.
Slovenian: Populacija je bila v glavnem sestavljena iz otrok z minimalnim hepatitisom B. Otroci, stari od 2 do 11 let, so jemali odmerek 3 mg/kg enkrat dnevno (do največjega odmerka 100 mg dnevno), mladostniki, stari 12 let in več, pa so jemali odmerek 100 mg enkrat dnevno.
English: Frequency categories are only assigned to those adverse reactions considered to be at least possibly causally related to lamivudine.
Slovenian: Kategorije pogostnosti so omejene le na tiste neželene učinke, za katere obstaja vsaj možna vzročna povezava z lamivudinom.
English: The requirements for submission of periodic safety update reports for this medicinal products are set out in the list of Union reference dates (EURD list) provided for under Article 107c(7) of Directive 2001/83/EC and any subsequent updates published on the European medicines web-portal.
Slovenian: Zahteve glede predložitve rednega posodobljenega poročila o varnosti zdravila za to zdravilo so določene v seznamu referenčnih datumov EU (seznam EURD), opredeljenem v členu 107c(7)
English: A side effect which may show up in blood tests is: • a decrease in the number of cells involved in blood clotting (thrombocytopenia).
Slovenian: Neželeni učinek, ki se lahko pokaže pri preiskavah krvi, je: • zmanjšanje števila celic, ki sodelujejo pri strjevanju krvi (trombocitopenija).
English: At the end of 5 years, all patients had HBV DNA levels that were undetectable or lower than pre-treatment levels.
Slovenian: Po preteku 5 let so bile pri vseh bolnikih ravni HBV DNA nezaznavne ali nižje v primerjavi s stanjem pred zdravljenjem.
English: What Zeffix is and what it is used for 2.
Slovenian: Kaj je zdravilo Zeffix in za kaj ga uporabljamo 2.
English: If you take more Zeffix than you should
Slovenian: Če ste vzeli večji odmerek zdravila Zeffix, kot bi smeli
English: 5 to < 15
Slovenian: 5 do < 15
English: If you are already taking another medicine that contains lamivudine for HIV infection, your doctor will continue to treat you with the higher dose, (usually 150 mg twice a day), because the dose of lamivudine in Zeffix (100 mg) is not enough to treat HIV infection.
Slovenian: Če že jemljete kakšno drugo zdravilo, ki vsebuje lamivudin, za zdravljenje okužbe s HIV, vas bo zdravnik še naprej zdravil z višjim odmerkom (po navadi 150 mg dvakrat na dan), ker odmerek lamivudina v zdravilu Zeffix (100 mg) ne zadošča za zdravljenje okužbe s HIV.
English: Treatment with Zeffix can reduce the amount of hepatitis B virus in your body.
Slovenian: Zdravljenje z zdravilom Zeffix lahko zmanjša količino virusa hepatitisa B v vašem telesu.
English: 30 to < 50
Slovenian: 30 do < 50
English: For lamivudine-treated patients, the majority of post-treatment ALT elevations occurred between 8 and 12 weeks post-treatment.
Slovenian: Bolnikom, zdravljenim z lamivudinom, se je večina zvišanj ALT po zdravljenju pojavila od 8 do 12 tednov po zdravljenju.
English: Herts SG12 0DJ United Kingdom or
Slovenian: Herts SG12 0DJ Velika Britanija ali
English: Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Slovenian: Preobčutljivost na učinkovino ali za katerokoli pomožno snov, navedeno v poglavju 6.1.
English: The incidence of YMDD mutant HBV was similar to that observed in adults, ranging from 19 % at week 52 up to 45 % in patients treated continuously for 24 months.
Slovenian: Pojavnost YMDD mutanta HBV je bila podobna tisti, ki so jo opazili pri odraslih, v obsegu od 19 % v 52. tednu do 45 % pri bolnikih, ki so se kontinuirano zdravili 24 mesecev.
English: Elevations of CPK
Slovenian: Pogosti zvišanje CPK
English: 10 Close the bottle tightly with the cap.
Slovenian: 10 Stekleničko tesno zaprite z zaporko.
English: Some clinical findings also support a possible interaction between lamivudine and cladribine.
Slovenian: Tudi nekateri klinični izsledki potrjujejo možno medsebojno delovanje med lamivudinom in kladribinom.
English: When full, the applicator contains 10 ml of solution.
Slovenian: Ko je aplikator poln, vsebuje 10 ml raztopine.
English: The mean systemic clearance of lamivudine is approximately 0.3 l/h/kg.
Slovenian: Povprečni sistemski očistek lamivudina je približno 0,3 l/h/kg.
English: YMDD1 Non-YMDD1
Slovenian: Brez YMDD1
English: Patients should be informed that malaise and fatigue have been reported during treatment with lamivudine.
Slovenian: Bolnike je potrebno obvestiti, da so med zdravljenjem z lamivudinom poročali o slabem počutju in utrujenosti.
English: At the highest dosage levels, minor effects on indicators of liver and kidney function were seen together with occasional reduction in liver weights.
Slovenian: Pri največjih odmerkih so bili opaženi manjši učinki na pokazatelje jetrne in ledvične funkcije ter občasno zmanjšanje teže jeter.
English: The intracellular half life of the triphosphate in hepatocytes is 17-19 hours in vitro.
Slovenian: In vitro je znotrajcelični razpolovni čas trifosfata v hepatocitih od 17 do 19 ur.
English: Exacerbations after treatment discontinuation
Slovenian: Poslabšanja po prenehanju zdravljenja
English: When lamivudine therapy was continued post transplantation there was reduced graft re-infection by HBV, increased HBsAg loss and on one-year survival rate of 76 - 100 %.
Slovenian: Če se je zdravljenje z lamivudinom nadaljevalo po transplantaciji, je prišlo do zmanjšanja reinfekcij presadka s HBV, izginotje HBsAg je poraslo, stopnja enoletnega preživetja pa je bila med 76 in 100 %.
English: Rhabdomyolysis * In Phase III studies frequency observed in the lamivudine treatment group was not greater than observed in the placebo group
Slovenian: * V študijah III. faze pogostnost v skupini z lamivudinom ni bila večja od pogostnosti v skupini s placebom.
English: The mean lamivudine CSF/serum concentration ratio 2-4 hours after oral administration was approximately 0.12.
Slovenian: Povprečno razmerje CSF/serum koncentracij lamivudina 2 do 4 ure po peroralnem vnosu je bilo približno 0,12.
English: 1 Remove the child-proof bottle cap (A).
Slovenian: 1 Odstranite za otroke varno zaporko stekleničke (A).
English: Other side effects Other side effects have occurred in a very small number of people but their exact frequency is unknown
Slovenian: Ostali neželeni učinki so se pojavili pri zelo majhnem številu bolnikov, vendar njihova natančna pogostnost ni znana:
English: ULN = Upper limit of normal.
Slovenian: ZMN = zgornja meja normale
English: Contents of the pack and other information What Zeffix contains
Slovenian: Vsebina pakiranja in dodatne informacije Kaj vsebuje zdravilo Zeffix
English: Lamivudine-TP acts as a substrate for the HBV viral polymerase.
Slovenian: Lamivudin-TP deluje kot substrat za HBV virusno polimerazo.
English: The solution is clear, colourless to pale yellow in colour with strawberry/banana flavouring.
Slovenian: Peroralna raztopina je bistra, brezbarvna do bledo rumena raztopina z aromo jagode/banane.
English: Experience in patients with decompensated liver disease Placebo controlled studies have been regarded as inappropriate in patients with decompensated liver disease, and have not been undertaken.
Slovenian: Izkušnje pri bolnikih z dekompenzirano jetrno boleznijo S placebom nadzorovane študije pri bolnikih z dekompenzirano jetrno boleznijo se smatrajo kot neprimerne, zato niso bile izvedene.
English: Boxes containing 28 or 84 film-coated tablets in double foil blisters, laminated with polyvinyl chloride.
Slovenian: Škatle, ki vsebujejo 28 ali 84 filmsko obloženih tablet v pretisnem omotu, prevlečenem s polivinilkloridom.
English: If you accidentally take too much, tell your doctor or your pharmacist, or contact your nearest hospital emergency department for further advice.
Slovenian: Če po nesreči vzamete prevelik odmerek, se za dodatni nasvet obrnite na svojega zdravnika ali farmacevta ali pa na urgentni oddelek najbližje bolnišnice.
English: Substances shown to be predominately excreted either via the active organic anionic pathway, or by glomerular filtration are unlikely to yield clinically significant interactions with lamivudine.
Slovenian: Malo je verjetno, da bi učinkovine, za katere se je izkazalo, da se primarno izločajo bodisi preko aktivne organske anionske poti bodisi z glomerularno filtracijo, povzročile klinično pomembne interakcije z lamivudinom.
English: See section 3 for more information about how to take Zeffix.
Slovenian: Glejte poglavje 3 za nadaljnja navodila v zvezi z jemanjem zdravila Zeffix.
English: The standard recommended procedures for hepatitis B virus immunisation in infants should be followed.
Slovenian: Slediti je treba standardnim priporočenim postopkom za imunizacijo otrok proti hepatitisu B.
English: Frequency of emergence of YMDD mutant HBV and impact on the treatment response Lamivudine monotherapy results in the selection of YMDD mutant HBV in approximately 24 % of patients following one year of therapy, increasing to 69 % following 5 years of therapy.
Slovenian: Pogostnost pojava YMDD mutanta in vpliv na odziv na zdravljenje Monoterapija z lamivudinom privede do selekcije YMDD mutanta HBV pri približno 24 % bolnikov po enem letu zdravljenja in po 5-ih letih zdravljenja naraste do 69 %.
English: • if you're allergic to lamivudine or to any of the other ingredients of this medicine (listed in
Slovenian: • če ste alergični na lamivudin ali katerokoli drugo sestavino tega zdravila (navedeno v poglavju
English: 100 mg once daily, Cmax is in the order of 1.1-1.5 µg/ml and trough levels were 0.015-0.020 µg/ml.
Slovenian: Pri vrednostih terapevtskega odmerka, npr. 100 mg enkrat dnevno, se Cmax giblje v intervalu med 1,1 in 1,5 μg/ml, najnižje koncentracije pa so 0,015 do 0,020 μg/ml.
English: Continued lamivudine treatment for an additional 2 years in patients who had failed to achieve HBeAg seroconversion in the initial 1 year controlled studies resulted in further improvement in bridging fibrosis.
Slovenian: Nadaljevanje zdravljenja z lamivudinom še dodatni 2 leti je pri bolnikih, pri katerih v začetnih enoletnih nadzorovanih študijah ni prišlo do serokonverzije HBeAg, privedlo do nadaljnjega izboljšanja fibroze.
English: Zeffix contains sugar and preservatives
Slovenian: Zdravilo Zeffix vsebuje sladkor in konzervanse
English: Forty patients (HBeAg negative or HBeAg positive) with either decompensated liver disease or recurrent HBV following liver transplantation and YMDD mutant were enrolled into an open label arm of study NUC20904.
Slovenian: Štirideset bolnikov (HBeAg negativni ali HBeAg pozitivni) z dekompenzirano jetrno boleznijo ali rekurentnim HBV po transplantaciji jeter in YMDD mutantom je bilo prav tako vključenih v odprti del študije NUC20904.
English: Use the oral applicator supplied with the pack to measure your dose accurately (see also Section 3).
Slovenian: Za točno merjenje odmerka uporabite peroralni aplikator, ki je priložen v pakiranju (glejte tudi poglavje 3).
English: Lamivudine had no effect on the pharmacokinetics of trimethoprim or sulphamethoxazole.
Slovenian: Lamivudin nima učinka na farmakokinetiko trimetoprima ali sulfametoksazola.
English: Lamivudine is metabolised by both infected and uninfected cells to the triphosphate (TP) derivative which is the active form of the parent compound.
Slovenian: Lamivudin se presnavlja tako v okuženih kot v neokuženih celicah v trifosfatni derivat (TP), ki je aktivna oblika izvorne učinkovine.
English: If lamivudine is discontinued, patients should be periodically monitored for evidence of recurrent hepatitis (see section 4.4).
Slovenian: Če se zdravljenje lamivudinom prekine, je treba bolnike periodično nadzirati glede dokazov rekurentnega hepatitisa (glejte poglavje 4.4).
English: The pack also includes a polyethylene applicator-adapter, and a 10 ml oral applicator comprised of a polypropylene barrel (with ml graduations) and a polyethylene plunger.
Slovenian: Škatli je priložen tudi polietilenski nastavek za aplikator in 10 ml peroralni aplikator, ki vsebuje polipropilensko cev (z mililitersko lestvico) in polietilenskim batom.
English: 15 to < 30
Slovenian: 15 do < 30
English: HBeAg seroconversion
Slovenian: Serokonverzija HBeAg
English: Dose reduction in patients with a creatinine clearance of < 50 ml/min is necessary (see section 4.2).
Slovenian: Pri bolnikih z očistkom kreatinina < 50 ml/min je treba odmerek zmanjšati (glejte poglavje 4.2).
English: For the treatment of patients who are co-infected with HIV and are currently receiving or plan to receive treatment with lamivudine or the combination lamivudine-zidovudine, the dose of lamivudine prescribed for HIV infection (usually 150 mg/twice daily in combination with other antiretrovirals) should be maintained.
Slovenian: Pri zdravljenju bolnikov, ki so sočasno okuženi z virusom HIV in se trenutno že zdravijo ali pa se zanje načrtuje zdravljenje z lamivudinom ali kombinacijo lamivudin-zidovudin, je potreben vzdrževalni odmerek lamivudina, ki je predpisan za okužbo z virusom HIV (običajno 150 mg/dvakrat dnevno v kombinaciji z drugimi protiretrovirusnimi zdravili).
English: Since lamivudine is dialysable, continuous haemodialysis could be used in the treatment of overdose, although this has not been studied.
Slovenian: Ker se lamivudin izloča z dializo, se v primeru prevelikega odmerjanja lahko uporabi kontinuirana hemodializa, vendar pa to še ni preučeno.
English: Due to the marginal liver function in these patients, hepatitis reactivation at discontinuation of lamivudine or loss of efficacy during treatment may induce severe and even fatal decompensation.
Slovenian: Zaradi mejne funkcijske sposobnosti jeter pri takšnih bolnikih lahko ponoven zagon hepatitisa ob prekinitvi zdravljenja z lamivudinom ali izgubi učinkovitosti med zdravljenjem sproži hudo in celo smrtno dekompenzacijo.
English: These medicines should not be used with Zeffix:
Slovenian: Zdravila, ki se ne smejo uporabljati skupaj z zdravilom Zeffix:
English: Table 2: Efficacy results 5 years by YMDD status (Asian Study) NUCB3018
Slovenian: Preglednica 2: Rezultati učinkovitosti v 5 letih glede na status YMDD (Azijska študija)
English: Butterscotch coloured, film-coated, capsule shaped, biconvex, approximate dimensions 11mm x 5mm and engraved “GX CG5” on one face.
Slovenian: Karamelne barve, filmsko obložena, v obliki kapsule, bikonveksna, približne dimenzije 11 mm x 5 mm, z na eni strani vtisnjeno oznako “GX CG5”.
English: The dosage should, therefore, be reduced for patients with a creatinine clearance of < 50 ml/minute.
Slovenian: Tako je treba pri bolnikih z očistkom kreatinina < 50 ml/minuto odmerek zmanjšati.
English: 3 Abbott Genostics solution hybridisation assay (LLOD < 1.6 pg/ml 4 Chiron Quantiplex assay (LLOD 0.7 Meq/ml)
Slovenian: Abbott Genostics hibridizacijski test v raztopini (LLOD < 1,6 pg/ml) Chiron Quantiplex test (LLOD 0,7 Meq/ml)
English: If overdose occurs the patient should be monitored and standard supportive treatment applied as required.
Slovenian: V primeru prevelikega odmerjanja je treba bolnika nadzirati in po potrebi uvesti standardno podporno zdravljenje.
English: Other medicines and Zeffix
Slovenian: Druga zdravila in zdravilo Zeffix
English: Exacerbations in patients with decompensated cirrhosis Transplantation recipients and patients with decompensated cirrhosis are at greater risk from active viral replication.
Slovenian: Prejemniki presajenih organov in bolniki z dekompenzirano cirozo so v večji nevarnosti glede aktivne replikacije virusa.
English: The incidence of adverse reactions and laboratory abnormalities (with the exception of elevations of ALT and CPK, see below) were similar between placebo and lamivudine treated patients.
Slovenian: Pojavnost neželenih učinkov in laboratorijskih abnormalnosti (z izjemo zvišanja ALT in CPK, glejte spodaj) je bila podobna pri bolnikih, ki so se zdravili s placebom in pri bolnikih, ki so se zdravili z lamivudinom.
English: Pharmacotherapeutic group - Antivirals for systemic use, nucleoside and nucleotide reverse transcriptase inhibitors, ATC Code: J05AF05.
Slovenian: Farmakoterapevtska skupina:Zdravila za sistemsko zdravljenje virusnih infekcij, nukleozidni in nukleotidni inhibitorji reverzne transkriptaze, oznaka ATC: J05AF05.
English: In patients with chronic hepatitis B there was no observed difference in incidence of these events between placebo and lamivudine treated patients.
Slovenian: Pri bolnikih s kroničnim hepatitisom B niso opazili razlik v pojavnosti teh dogodkov, če so bili bolniki zdravljeni s placebom ali lamivudinom.
English: Normalisation of ALT levels occurred in 31 % (14/45) of patients receiving combined therapy versus 6 % (3/47) receiving lamivudine alone.
Slovenian: Normalizacija vrednosti ALT se je pojavila pri 31 % (14/45) bolnikov, ki so imeli kombinirano zdravljenje, v primerjavi s 6 % (3/47) pri tistih, ki so prejemali samo lamivudin.
English: ALT normalisation
Slovenian: Normalizacija ALT
English: The oral applicator is provided for accurate measurement of the prescribed dose of oral solution.
Slovenian: Za natančno odmerjanje predpisanega odmerka peroralne raztopine je priložen peroralni aplikator.
English: This will mean taking blood samples to check for any raised liver enzyme levels, which may indicate liver damage.
Slovenian: Jemal vam bo vzorce krvi in preverjal morebitne povišane vrednosti jetrnih encimov, ki lahko kažejo na okvaro jeter.
English: Data is available from an extended treatment study in HBeAg negative patients (NUCAB3017) treated with lamivudine.
Slovenian: Podatki so na voljo iz študije s podaljšanim zdravljenjem (NUCAB3017) pri HBeAg negativnih bolnikih, ki so se zdravili z lamivudinom.
English: The pack includes an oral applicator with ml graduations and an applicator-adapter, which should be fitted to the bottle before use.
Slovenian: Škatli je priložen peroralni aplikator z merilno skalo v ml in nastavek za aplikator, ki ga je treba pred uporabo namestiti na plastenko.
English: Some lateonset neurological disorders have been reported (hypertonia, convulsion, abnormal behaviour).
Slovenian: Opisane so nekatere nevrološke motnje s poznim nastankom (hipertonija, konvulzije, nenormalno vedenje).
English: Zidovudine had no effect on the pharmacokinetics of lamivudine (see section 5.2).
Slovenian: Zidovudin ni imel učinka na farmakokinetiko lamivudina (glejte poglavje 5.2).
English: Renal clearance accounts for about 70 % of lamivudine elimination.
Slovenian: Približno 70 % izločenega lamivudina gre na račun ledvičnega očistka.
English: What you need to know before you take Zeffix 3.
Slovenian: Kaj morate vedeti, preden boste vzeli zdravilo Zeffix 3.
English: • a decrease in the number of cells involved in blood clotting (thrombocytopenia).
Slovenian: • zmanjšanje števila celic, ki sodelujejo pri strjevanju krvi (trombocitopenija).
English: Interactions with other medicinal products
Slovenian: Interakcije z drugimi zdravili
English: The tablets are butterscotch coloured, capsule shaped, biconvex and engraved “GX CG5” on one side.
Slovenian: Tablete so karamelne barve, v obliki kapsule, bikonveksne in imajo na eni strani vtisnjeno oznako “GX CG5”.
English: Lamivudine is predominantly eliminated by active organic cationic secretion.
Slovenian: Lamivudin se pretežno izloča z aktivno sekrecijo organskih kationov.
English: What Zeffix is and what it is used for
Slovenian: Kaj je zdravilo Zeffix in za kaj ga uporabljamo